[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$fH_ozr_kT9rZJ2sENSDLmibAIapaiEP6MNVIDg9mexzk":3},{"locale":4,"topic":5,"relatedTrends":46},"en",{"topic":6,"slug":7,"canonicalSlug":7,"topicAliases":8,"nicheKey":9,"nicheName":10,"nicheNameEn":11,"nicheIcon":12,"country":13,"countries":14,"agentKey":15,"score":16,"type":17,"isFresh":18,"detectedAt":19,"sources":20,"evidence":43},"Huntington's disease therapies under investigation in 2026 pipeline","huntington-s-disease-therapies-under-investigation-in-2026-pipeline",[],"sante","Santé & Médecine","Health & Medicine","🏥","US",[13],"sante-US",98,"spiking",true,"2026-05-19T01:45:57.454Z",[21,27,33,38],{"title":22,"url":23,"domain":24,"snippet":25,"content":26},"Huntington's Disease Pipeline 2026: Therapies Under","https:\u002F\u002Fwww.openpr.com\u002Fnews\u002F4517344\u002Fhuntington-s-disease-pipeline-2026-therapies-under","openpr.com","DelveInsight's 2026 report outlines investigational therapies, clinical trial milestones, and development progress for Huntington's disease treatments.","Consent to Cookies & Data processing\n\nWe use cookies in accordance with our privacy policy linked below to process end device information and personal data. This serves the integration of content, external services and elements of third parties, statistical analysis\u002Fmeasurement, personalized advertising as well as the integration of social media. Depending on the function, data is thereby passed on to third parties, also in the USA, with the risk of secret access by US authorities and use for monitoring purposes, possibly also without any legal remedy, and processed by them. By clicking the \"Accept All\" button, you consent to the above use. This consent is voluntary and can be revoked at any time via the \"Cookie Settings\" link at the very bottom of the website footer. If you click on the \"Reject all\" button, only essential cookies that are necessary for the operation of the website will be set. At the bottom left via \"Advanced settings\" you can select in detail which cookies you want to allow.\n\nGoogle Analytics\n\nStore and\u002For access information on a device\n\nUse limited data to select advertising\n\nCreate profiles for personalised advertising\n\nUse profiles to select personalised advertising\n\nMeasure advertising performance\n\nMeasure content performance\n\nUnderstand audiences through statistics or combinations of data from different sources\n\nDevelop and improve services\n\n |  |  | [Legal notice](https:\u002F\u002Fwww.op\n\n[Content truncated...]",{"title":28,"url":29,"domain":30,"snippet":31,"content":32},"ASGCT Q1 Landscape Report Paints Positive Picture for Gene and RNA Therapy","https:\u002F\u002Fwww.genengnews.com\u002Fnews\u002Fasgct-q1-landscape-report-paints-positive-picture-for-gene-and-rna-therapy\u002F","genengnews.com","The American Society for Gene and Cell Therapy (ASGCT) CEO David Barrett, JD, noted there has been “a nice uptick” in Q1 in start-up funding compared to the...",null,{"title":34,"url":35,"domain":36,"snippet":37,"content":32},"Why PTC Therapeutics (PTCT) Is Up 12.5% After Beating Q1 Estimates And Lifting 2026 Guidance","https:\u002F\u002Fwww.sahmcapital.com\u002Fnews\u002Fcontent\u002Fwhy-ptc-therapeutics-ptct-is-up-125-after-beating-q1-estimates-and-lifting-2026-guidance-2026-05-11","sahmcapital.com","In early May 2026, PTC Therapeutics reported first-quarter revenue of US$272.55 million versus US$1.18 billion a year earlier, swinging from net income of...",{"title":39,"url":40,"domain":41,"snippet":42,"content":32},"What Just Happened with uniQure's Earnings and FDA Update","https:\u002F\u002Fwww.kavout.com\u002Fmarket-lens\u002Fwhat-just-happened-with-uniqure-s-earnings-and-fda-update","kavout.com","uniQure (QURE) stock dropped over 37% after a mixed earnings report. The FDA rejected their AMT-130 data package for Huntington's disease, recommending a...",{"mentionsLast7Days":44,"mentionsLast30Days":44,"firstSeen":19,"lastSeen":19,"relatedEntities":45},4,[23,29,35,40],[47,51,54,57,60,64],{"topic":48,"slug":49,"score":50,"type":17,"country":13,"nicheIcon":12},"Rapid advancement of AI in medical imaging market and adoption drivers","rapid-advancement-of-ai-in-medical-imaging-market-and-adoption-drivers",100,{"topic":52,"slug":53,"score":50,"type":17,"country":13,"nicheIcon":12},"trimming damaged meniscus (arthroscopic partial meniscectomy) offers no benefit","trimming-damaged-meniscus-arthroscopic-partial-meniscectomy-offers-no-benefit",{"topic":55,"slug":56,"score":50,"type":17,"country":13,"nicheIcon":12},"Mayo Clinic nonprofit medical centers and healthcare services","mayo-clinic-nonprofit-medical-centers-and-healthcare-services",{"topic":58,"slug":59,"score":16,"type":17,"country":13,"nicheIcon":12},"Electronic health record systems: functions, implementation, issues","electronic-health-record-systems-functions-implementation-issues",{"topic":61,"slug":62,"score":63,"type":17,"country":13,"nicheIcon":12},"Electronic health record systems' description, implementation, and challenges","electronic-health-record-systems-description-implementation-and-challenges",95,{"topic":65,"slug":66,"score":67,"type":17,"country":13,"nicheIcon":12},"Electronic health record systems for patient health information","electronic-health-record-systems-for-patient-health-information",91]